The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504.
 
Robert L. Ferris
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Benitec Biopharma; Bristol-Myers Squibb; EMD Serono; Lilly; Merck; Pfizer
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; VentiRx
 
Maura L. Gillison
Consulting or Advisory Role - Aspyerian Therapeutics; AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Jonathan Harris
No Relationships to Disclose
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Curis; Genentech
 
Loren K. Mell
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Christina Kong
No Relationships to Disclose
 
Richard Jordan
Stock and Other Ownership Interests - Genomic Health
 
Kevin Moore
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - 3D knowledge-based planning patent pending (Owner: UC San Diego) (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
 
Minh Tam Truong
No Relationships to Disclose
 
Claudia Kirsch
No Relationships to Disclose
 
David Anthony Clump
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
Dukagjin Blakaj
No Relationships to Disclose
 
John F. Deeken
No Relationships to Disclose
 
Mitchell Machtay
Research Funding - Lilly/ImClone
 
Walter John Curran
Stock and Other Ownership Interests - Nanthealth
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - Varian Medical Systems; Vertex
Research Funding - Abbvie (Inst)
 
Quynh-Thu Le
Stock and Other Ownership Interests - Aldea
Research Funding - Amgen (Inst); RedHill Biopharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Varian Medical Systems